Can Perimenopause Cause Kidney Stones? What the Research Actually Says

Can perimenopause really cause kidney stones?

It can, and the data is stronger than most women - or their doctors - realize. A 2023 study in Annals of Epidemiology followed 17,460 women and found the postmenopausal group had double the prevalence of kidney stone disease compared to premenopausal women (6% vs. 3%), with an adjusted odds ratio of 1.50 (Tang et al., 2023). That is a 50% increase in risk, adjusted for age, BMI, and other confounders.

The shifting epidemiology makes this even more striking. A longitudinal analysis drawing on the Nurses' Health Study and Health Professionals Follow-up Study found that the traditional male predominance in kidney stones is narrowing, with women now accounting for a rising share of new cases - and the timing maps onto the menopausal transition, as falling estrogen erodes the metabolic protection women historically carried (Ferraro, Taylor & Curhan, 2023).

Kidney stones rarely come up in perimenopause conversations because they do not fit the reproductive-symptom story most women are handed. But menopause is a whole-body metabolic event, not just a change to your cycle. The same estrogen decline driving irregular periods, night sweats, and rising blood pressure also alters how your kidneys filter calcium, process uric acid, and maintain the chemical balance that prevents mineral crystallization.

Most women who pass a first kidney stone in their 40s are told to drink more water and sent home with no further investigation. The hormonal context is almost never raised. If you are in the perimenopause transition when it happens, the estrogen decline is the most likely systemic explanation for why your urine chemistry shifted enough to allow a stone to form - and that context changes how prevention needs to be framed.

Why does estrogen protect against kidney stone formation?

The hormone connection to kidney stone risk is direct and measurable. A large NHANES analysis examining sex hormones and kidney stone history found that higher serum estradiol was significantly associated with lower odds of kidney stone disease in women, independent of age and menopausal status (Nackeeran et al., 2021). As estradiol falls through perimenopause, that protective association weakens in a dose-dependent way - which means the transition itself, not just the postmenopausal endpoint, is when kidney stone risk begins climbing.

The primary mechanism runs through urinary citrate. Citrate is the kidneys' built-in stone inhibitor: it binds calcium in urine and prevents it from combining with oxalate or phosphate to form solid crystals. Estrogen appears to support citrate excretion directly - which is why postmenopausal women tend to show lower urinary citrate compared to premenopausal women even without any change in diet or fluid intake.

Estrogen also buffers metabolic acid load. When estrogen is adequate, urine tends toward a more neutral pH. As it falls, urine can drift more acidic - the precise environment where uric acid crystallizes most readily. This is why uric acid stones, while still a minority type, become relatively more common after the menopausal transition even in women who have never had one before.

Why does kidney stone risk go up during perimenopause?

Several mechanisms converge during the transition, and none require you to be doing anything wrong. The Nurses' Health Study II prospectively followed 108,639 women and performed 24-hour urine collections across menopausal stages - confirming that postmenopausal status was independently linked to elevated stone risk and measurable shifts in the urine chemistry that drives stone formation (Prochaska, Taylor & Curhan, 2018).

Three forces work together. First, urinary citrate drops as estrogen falls, removing the chemical brake that normally prevents calcium and oxalate from crystallizing into deposits. Second, bone remodeling accelerates with the loss of estrogen's bone-protecting effect - more calcium enters the bloodstream and filters into urine, raising the crystallization load directly. Third, the rising insulin resistance that tracks perimenopause pushes urine toward an acidic pH that specifically favors uric acid stone formation.

Add in the mild chronic dehydration many women carry in their 40s - worsened by night sweats and hot flashes, which cause measurable fluid loss without the thirst signal that normally compensates - and all of these mineral risks concentrate simultaneously, often without any obvious dietary trigger.

What kind of kidney stones are more common in perimenopause?

Calcium oxalate stones are the most common type at any age and that does not change in perimenopause. However, understanding the full picture of urine chemistry matters for prevention. A 2024 analysis using 24-hour urine collections from large cohort data confirmed that greater urine volume, higher urinary citrate, and higher potassium and magnesium were independently associated with lower stone risk - while higher calcium, oxalate, and sodium each raised it (Ferraro, Taylor & Curhan, 2024). During perimenopause, the combination of lower citrate and insufficient hydration is particularly relevant because both shift in the wrong direction without any dietary decision on your part.

Uric acid stones - roughly 10-15% of all stones at baseline - become relatively more prevalent after menopause, largely because rising insulin resistance shifts urine toward the acidic pH where uric acid crystallizes most readily. The distinction matters for treatment: calcium oxalate stones are sensitive to hydration and dietary oxalate, while uric acid stones can sometimes dissolve with targeted alkalinization. Knowing which type you have shapes the practical response.

Both types concentrate when urine does, from inadequate fluid intake, high-sodium eating, or the thirst dysregulation that perimenopause causes in some women. Night sweats alone can reduce overnight fluid volume enough to measurably raise morning urine concentration. The simplest real-time signal is urine color: pale yellow means adequate hydration; dark amber means mineral concentrations are rising and stone risk is climbing with them. Concentrated urine also shifts the bacterial balance and pH that govern how urine smells in perimenopause -- both risks share the same estrogen-driven root.

Is it a kidney stone, a UTI, or something else?

This distinction matters because the two most common urinary complaints in perimenopause can feel similar but require completely different responses. A kidney stone typically produces flank pain - in the back below the ribs on one side - that waves in intensity and may radiate toward the groin or inner thigh. Nausea and blood in urine are common; the burning on urination that marks a UTI usually is not present.

A UTI produces urgency, frequency, and burning - often with little or no flank pain unless the infection has traveled up to the kidneys, which is a urinary emergency. If you have recurring UTIs and unexplained back or flank pain, both deserve evaluation. Perimenopause increases vulnerability to each through overlapping estrogen-driven mechanisms - the same tissue thinning that makes the urinary tract vulnerable to infection also changes urine chemistry in ways that raise stone risk.

Sudden, severe flank pain is a reason to seek same-day evaluation. A urinalysis and imaging can distinguish a stone from an infection quickly and guide the right response. Do not wait and see with significant one-sided flank pain - the cause matters, and the treatments are completely different.

Does hormone therapy affect kidney stone risk?

The data here is more nuanced than a simple yes or no. The 2023 Tang study found that current hormone therapy users had a lower prevalence of kidney stone disease than non-users among postmenopausal women - consistent with the biology: estrogen supports the urinary citrate excretion that inhibits stone formation and buffers against the metabolic shifts that drive mineral concentration in urine.

HRT decisions are always individual. If you have a history of kidney stones and are considering hormone therapy, surfacing that history with your prescribing doctor is worth doing - not because HRT is contraindicated, but because optimizing the full metabolic picture alongside hormonal support gives the best outcome. Calcium supplementation practices, vitamin D levels, and hydration habits all interact with hormonal status in ways that affect urine chemistry. The metabolic lever is often larger than the hormonal one, and the most effective approach usually involves addressing both.

What actually helps reduce kidney stone risk in perimenopause?

The evidence-based interventions are practical and most cost nothing. Hydration is the primary lever: adequate fluid intake keeps mineral concentrations below the crystallization threshold. The target is roughly 2 to 2.5 liters of fluid daily, more with heat or exercise. You can cross-check your baseline eating and hydration habits against the perimenopause nutrition checklist.

Reduce sodium, not calcium. Dietary sodium increases urinary calcium directly; cutting processed foods and excess salt meaningfully lowers stone-forming calcium in urine. Dietary calcium is paradoxically protective - it binds oxalate in the gut and prevents it from reaching the kidneys. Restricting calcium often makes calcium oxalate stone risk worse. If you eat oxalate-rich foods like spinach, nuts, or beets regularly, pairing them with a calcium source at the same meal limits how much oxalate the kidneys see.

Lemon juice in water genuinely helps: the citric acid raises urinary citrate, adding back the natural stone inhibitor that perimenopause is depleting. A half-lemon squeezed into water daily is the most accessible citrate intervention with real evidence behind it and zero downside.

Diet pattern matters at the systems level too. A prospective analysis across three large cohorts - the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-up Study - found that higher adherence to the Mediterranean diet was associated with significantly lower risk of incident kidney stones, driven by its combination of plant foods, low sodium, adequate calcium, and anti-inflammatory profile (Rodriguez et al., 2020). If you are already working toward anti-inflammatory eating patterns, kidney stone prevention is a meaningful downstream benefit.

At the metabolic level, strength training, protein-anchored meals, and consistent sleep stabilize the insulin sensitivity and urine pH that make stone formation less likely over time. The Estrogen Left the Chat: Biohacking Menopause framework covers the metabolic architecture underlying most of these downstream symptoms - kidney stones included - and gives you the full picture of what is actually shifting systemically and why.

My Perspective

Nobody warned me that menopause could show up in my kidneys. I genuinely assumed kidney stones were a man problem - too little water, too much beer - until I started mapping what declining estrogen actually does to the body, system by system. This pattern kept appearing: symptoms that look completely unrelated to hormones, starting specifically in the perimenopause window, with a clear biological explanation once someone draws the connecting line. Brain fog, jitters, weird pains, and now - urine chemistry that spontaneously starts forming rocks.

What I find most useful about the kidney stone connection is that it forces the broader question: if menopause can alter urine chemistry, bone mineral release, and metabolic pH, what else is it doing that nobody is naming? The answer is quite a lot. Menopause is not a single event; it is a years-long metabolic reconfiguration that shows up in places doctors are not trained to connect back to hormones.

If you are in your 40s and experiencing urinary symptoms you cannot explain, the free 60-second quiz is a worthwhile starting point for understanding your hormonal picture. And if you want to understand the systemic biology - not just the individual symptoms but the underlying architecture driving all of them - that is exactly what Estrogen Left the Chat is for.

A note from Marilyn: This article is for educational purposes and does not constitute medical advice. I am a nutrition specialist, not a physician. If you experience significant flank pain, recurrent kidney stones, or urinary symptoms that concern you, please consult a urologist or your primary care provider. Kidney stones can sometimes indicate underlying metabolic conditions that benefit from formal medical evaluation.